Computed tomographic-guided iodine-125 interstitial implants for malignant thoracic tumors

Search and removal of radioactive seeds: another application of postmortem computed tomography prior to autopsy

“…Such migration is frequently observed in patients with these implants (1.7 to 69.4 %) [15] and occurs in many sites of the body including the liver, kidneys, and vertebral column [16][17][18]. Additionally, recent reports show that permanent brachytherapy can now be used to treat cancers in many other parts of the body, which increases the challenge of finding the seeds [19][20][21]. Whole-body X-ray CT screening could indicate any locations of the seeds and is a valuable tool to include in pre-autopsy risk management protocols.…”

Computed tomography-guided implantation of 125 I seeds brachytherapy for recurrent multiple pulmonary oligometastases: initial experience and results

“…Computed tomographic and fluoroscopic-guided brachytherapy with 125 I seeds implantation is a safe, feasible, and effective modality for the treatment of inoperable early-stage non-small-cell lung cancer (NSCLC) [18]. 125 I implants for the treatment of lung cancer or malignant thoracic tumors showed local control rates ranging from 81% at 6 months to 75.3% at 3 years [19, 20]. …”

The value of spectral imaging to reduce artefacts in the body after 125I seed implantation

“…125 I seed implantation within tissues is mainly applied to patients with inoperable tumours or those refusing operations. The growth and development of the tumour can be inhibited maximally; the damage to the surrounding normal tissues can be reduced; and the survival rate and quality of life of patients could be improved . CT examination is necessary to follow‐up the therapy's effects after implantation of 125 I particles.…”